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Background: N-terminally truncated A(11-40/42) 
typically constitutes 19% of plaque load in 
Alzheimer’s patients. 
 
Results: Cu
2+
 binds to A(11-40) with a 34 
femtomolar dissociation constant and stabilizes 
very short highly amyloidogenic amyloid rods into 
longer A fibres. 
 
Concussion: The very tight affinity explains the 
high levels of Cu
2+
 in amyloid plaques. 
 
Significance: Copper, tightly bound to A(11-40/42) 
may influence disease pathology. 
 
 
ABSTRACT  
Alzheimer’s disease (AD) coincides with the 
formation of extracellular amyloid plaques 
composed of the amyloid- (A) peptide. A is 
typically forty residues long (A(1-40)) but can have 
variable C- and N-termini.  Naturally occurring N-
terminally truncated A(11-40/42) is found in the 
cerebrospinal fluid and has a similar abundance to 
A(1-42), constituting one fifth of the plaque load. 
Based on its specific N-terminal sequence we 
hypothesized that truncated A(11-40/42) would have 
an elevated affinity for Cu
2+
. Various 
spectroscopic techniques, complimented with 
transmission electron microscopy, were used to 
determine the properties of the Cu
2+
A(11-40/42) 
interaction and how Cu
2+
 influences amyloid fibre 
formation. We show Cu
2+
A(11-40) forms a 
tetragonal complex with a 34 ± 5 femtomolar 
dissociation constant at pH 7.4. This affinity is 
three orders of magnitude tighter than Cu2+ 
binding to A(1-40/42) and more than an order of 
magnitude tighter than that of serum albumin, the 
extracellular Cu2+ transport protein.  
Furthermore, A(11-40/42) forms fibres twice as fast 
as A(1-40) with a very different morphology; 
forming bundles of very short amyloid rods. 
Substoichiometric Cu
2+
 drastically perturbs A(11-
40/42) assembly, stabilizing much longer fibres. The 
very tight femtomolar affinity of Cu
2+
 for A(11-
40/42) explains the high levels of Cu
2+
 observed in 
AD plaques.  
 
 
The most prevalent form of fatal 
neurodegenerative disease is Alzheimer’s disease 
(AD) which directly affects more than 30 million 
people worldwide (1). At the center of AD 
pathogenesis is the misfolding and self-assembly 
of an endogenous peptide, amyloid-beta (A), into 
oligomers and amyloid fibres found in the 
extracellular plaques of AD patients (2). A is 
released as a cleavage product of the amyloid 
precursor protein (APP) by the action of the  and 
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 secretase complex, shown in Figure 1. These 
secretases, which have variable site specificity for 
APP, produce different lengths of A, reviewed by 
Kummer and Heneka (3).  
In addition to variable C-terminal cleavage, with 
A reportedly being 39-43 residues in length (4,5). 
N-terminally truncated A is also prominent in 
AD plaques. Exopeptidases such as 
aminopeptidase A are thought to be responsible 
for removing single residues from the N-terminus 
of the peptide (6-8). However the main N-
truncated form of A is generated by a secondary 
-secretase activity (ʹ) localized to the trans-
Golgi network which produces an N-terminally 
truncated A(11-40/42), see Figure 1 (9,10). A(11-
40/42) has also been identified as one of the main 
allotypes of A in cerebrospinal fluid (CSF) (11). 
It is perhaps not widely appreciated that isolated 
plaques from sporadic AD patients show A(11-42) 
with a similar abundance to A(1-42) with relative 
proportions of: A(1-40) 45.8%; A(1-42) 18.1% and 
A(11-42) 18.6% (12). A(11-40/42) and the N-terminal 
pyroglutamate allotype (pE A(11-40/42)) constitutes 
19% of the relative A load in the plaques of AD 
and young adults with Downs syndrome (13). 
Pyroglutamate (pE) at the N-terminal glutamate is 
generated by the action of the enzyme glutaminyl 
cyclase but the relative proportions of glutamate to 
pE are not well described (14). It is also thought 
that pE forms slowly over time, for example A(11-
40/42) detected in mouse models of AD contained no 
pyroglutamate, perhaps because these plaques 
form within 14 months (15). Interestingly, 
immunofluorescence has shown that pE A(11-40/42) 
is concentrated at the core of plaques in AD 
brains; supporting the hypothesis that A(11-40/42) 
could be one of the first amyloidogenic allotypes 
of A to form plaques in AD (16). Furthermore 
mutations in presenilin-1 (PS1) linked with 
familial AD, increase levels of A(1-42) but also, 
importantly A(11-42) (17). Despite the prevalence 
of A(11-40/42) in plaques and CSF, perhaps due to 
its poor solubility (18), very little is known about 
its amyloid forming properties in vitro or its 
synaptotoxicity.  
There is considerable interest in the interaction of 
metal ions with A(19). Cu2+ in particular, 
influences fibre formation and toxicity of A(1-40) 
and A(1-42) (19-24). The parenchymal copper 
concentration is at least four times higher in AD 
brains and Cu
2+
 is bound directly to A in plaques 
(25-28). Changes in copper homeostasis 
exacerbate disease phenotype in rabbit and 
drosophila models of AD (29-31). Furthermore, 
sequestering copper with chelators such as 
clioquinol, or its derivatives, lowers A aggregate 
load, maintains the health of AD mice and reduces 
toxicity in models of AD (32-34).  Cu
2+ 
is 
thought to bind to A(1-40/42) with a 50-100 
picomolar dissociation constant (35-37) and 
there is a suggestion that A(1-40/42) may bind Cu
2+
 
with a tighter affinity than this in an aggregated 
form (36). However, although the fluxes of weakly 
bound synaptic Cu
2+ 
are thought to reach levels of 
15-200 M (38,39) it is still contested as to 
whether a 50 pM affinity is sufficient to retain 
Cu
2+ 
ions in the brain parenchyma in the presence 
of other endogenous Cu
2+ 
chelators. We wondered 
whether the concentration of Cu
2+ 
in plaques might 
in part be due to Cu
2+
 binding to A(11-40/42) with an 
even tighter affinity.  
Interestingly, this truncated A(11-40/42) contains a 
histidine (His13) two amino acids from the N-
terminal amino group. This bears a striking 
resemblance to the Cu
2+
 binding motif (NH2-
XxxXxxHis) at the N-terminus of human serum 
albumin (HSA) (40,41). This site is responsible for 
Cu
2+ 
transport in blood plasma (42) and has a tight 
1.0 picomolar affinity for Cu
2+
, while N-terminal 
tripeptide models possess a sub-picomolar affinity 
(43-46).  
Here we aim to characterize the amyloid forming 
properties of A(11-40) and A(11-42) and their 
interaction with Cu
2+
. We show for the first time 
that A(11-40/42) has heightened amyloidogenicity 
compared to A(1-40/42) and forms short amyloid rod 
shaped assemblies. Furthermore, we show Cu
2+
 
has an extremely tight, 34 ± 5 femtomolar 
dissociation constant for A(11-40) at pH 7.4, and 
has a marked influence on A(11-40) fibre formation 
and morphology. A(11-40/42) constitutes 19% of the 
plaque load and this work suggests that it is 
responsible for the high concentration of Cu
2+
 
found in the plaques of AD patients. 
 
EXPERIMENTAL PROCEDURES 
A Peptides—Peptides used were synthesized 
using F-moc deprotection chemistry, including:  
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A(1-40)  DAEFR HDSGY EVHHQ 
KLVFF AEDVG SNKGA IIGLM VGGVV 
A(11-40)  EVHHQ KLVFF AEDVG 
SNKGA IIGLM VGGVV 
A(11-42)  EVHHQ KLVFF AEDVG 
SNKGA IIGLM VGGVV IA  
These peptides, found in the CSF and plaques, 
include a free N-terminal amino group and C-
terminal carboxylate. Pentapeptide models of the 
Cu
2+ 
binding motif were C-terminally amidated to 
mimic the continuation of the peptide sequence in 
full length A(11-40/42). The peptides were removed 
from the resin and deprotected before being 
purified by reverse-phase high-performance liquid 
chromatography. The samples were characterized 
using mass spectrometry. Peptides with amidated 
C-termini and free N-terminal amino groups 
studied included NH2-EVHHQ-CONH2 and NH2-
EVHAQ-CONH2. Pentapeptides purchased from 
Generon Ltd. (Maidenhead, U.K.). Full length 
A(11-40), A(11-42) and A(1-40) purchased from EZ 
Biolabs (Carmel, IN, USA) and Cambridge 
Research Biochemicals (Billingham, U.K.). 
 
A Solubilization—All three A peptides, A(1-40), 
A(11-40) and A(11-42) were solubilized at a 
concentration of 100 M in water at pH 10.5 – 11, 
and then left at 4 ̊C for 48-72 hours. In our hands 
we found that this was the most effective 
solubilization method, as others have reported 
(47,48). It is clear that solubilized preparations of 
A(1-40) and A(11-40) are largely seed-free at pH 7.4 
as solubilized preparations typically have no ThT 
fluorescence at time zero and exhibit a distinctive 
lag-phase of over 20 hours for A(11-40) and 60 
hours for A(1-40). Freshly solubilized A(11-40) and 
A(1-40) peptides had no detectable assemblies 
under TEM. For A(1-40), the concentration was 
determined using tyrosine absorption at 280 nm 
ε280 = 1,280 cm
-1
M
-1
. A(11-40) and A(11-42) lack a 
tyrosine residue so the peptide absorbance at 214 
nm ε214 = 923 cm
-1
M
-1 
per amide was used (49). 
All lyophilized peptides typically contained 10 – 
20 % moisture by weight. Concentrations for 
A(11-40/42) were supported by the 1:1 saturation of 
the Cu
2+
 binding site, indicating that a very clear 
1:1 stoichiometry had been established for freshly 
solubilized A(11-40/42).  
 
Titrations—All chemicals were purchased from 
Sigma-Aldrich at the highest purity available, and 
UHQ water was used throughout (resistivity of 10
–
18
 –1 cm–1). Small aliquots of fresh aqueous stock 
solutions, typically 10 mM, were used to add 
metal ions (CuCl2·2H2O, NiCl2·6H2O) and 
competitive ligands, Glycine (500 mM) and L-
Histidine (50 mM) stocks for titrations. Titrations 
were conducted at pH 7.4 with adjustments made 
using 20-100 mM solutions of NaOH and HCl. pH 
measurements were made before and after 
spectroscopic measurements.  
 
Affinity Measurements—The conditional affinities 
at pH 7.4 were determined using glycine and L-
histidine as competing ligands. The range of 
competitor concentrations (glycine and histidine) 
with Cu
2+
:A(11-40) or Cu
2+
:A(11-15) (0.8 : 1.0) 
complexes were made up in advance and left for 
12 hours at pH 7.4 to ensure equilibrium had been 
reached. Repeat CD spectra were obtained over a 
few hours, to confirm equilibrium had been 
reached. The concentration of competitor required 
for equal molar equivalents of Cu
2+
 to be bound to 
both the A peptide and competitor was used to 
determine the affinity of Cu
2+
 for the A peptide 
using equation 1 (35,37,50). Cu
2+
free is the 
concentration of Cu
2+
 not bound to either 
competitor ligand or peptide.  
 
Kd =[Cu
2+
free] =
[Cu2+
total
] - [Cu2+bound to A]
1 + Ka1[Glyfree] + Ka1Ka2([Glyfree]
2
)
  
 
Equation 1 
 
At 50% saturation: 
 
[Glyfree] = [Glytotal] – 2[Cu(Gly)2]        Equation 2 
  
The Cu
2+
 affinities of each competitor at pH 7.4 
can be calculated. Ka1 and Ka2 at pH 7.4 are: 7.4 × 
10
5 
M
-1
, 7.4 × 10
4
 M
–1
 for Gly and 2.7 × 10
8 
M
-1
, 
2.1 × 10
6
 M
-1
 for His (51). 
 
 
Fibre growth assay—The kinetics of amyloid 
fibre formation were monitored using binding of 
Thioflavin T (ThT) to amyloid fibres, which 
induces ThT to fluoresce at 487 nm; this signal is 
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proportional to the amount of amyloid fibrils 
present (52). BMG-Galaxy and Omega FLUOstar 
fluorescence 96-well plate readers were used for 
the measuring of ThT fluorescence. Fluorescence 
readings were typically taken every 30 mins, 
following 30 seconds of gentle agitation. 
Fluorescence excitation and emission detection 
were obtained using filters at 440 nm and 490 nm 
respectively. Fibre growth kinetics are sensitive to 
a number of factors, including pH, concentration 
of A, agitation, ionic strength and temperature; 
consequently, measures were taken to reduce 
variance in these parameters. All A peptides were 
studied at 10 M and all fibre growth experiments 
were incubated at 30 C̊ in 30 mM HEPES buffer 
(due to its low affinity for Cu
2+
 ions) and 160 mM 
NaCl. The pH, a critical factor in rate of fibre 
growth, was adjusted to pH 7.4 if necessary with 
small additions of 20-100 mM NaOH and HCl. 
Variation between samples was measured to be 
0.05 pH units or less. 10 M of ThT was present 
(1:1 with A), which is optimal for tracking A 
amyloid growth (52).  
 
Growth curve analysis—Conversion of essentially 
monomeric A to amyloid fibres follows a 
characteristic growth curve, consisting of an initial 
lag-phase (nucleation) before a growth phase 
(elongation). A growth curve can be fitted to the 
data, to obtain a number of empirical parameters, 
using the following equation (53): 
  
𝑦 =  (𝜐𝑖 +  𝑚𝑖𝑥) + 
(𝜐𝑓 +𝑚𝑓𝑥 )
(1+𝑒
−(𝑥 − 
𝑥0
𝜏
)
)
     
Equation 3              
𝑦 represents fluorescent intensity, and 𝑥 represents 
time. Initial fluorescence intensity is represented 
by υi, υf represents the final fluorescence 
intensity, and 𝑥₀ is the time at which half maximal 
fluorescence is reached (t50). The conditional fibre 
growth rate (kapp) is obtained by 1/ τ and the lag-
time (tlag) by 𝑥₀ − 2τ.  Data was processed using 
KaleidaGraph 4.0. Typically 6 or more kinetic 
traces were used to extract kinetic parameters.  
Circular Dichroism (CD)—CD spectra were 
recorded at 25 °C on an Applied Photophysics 
Chirascan instrument between 250 and 700 nm, 
with sampling points every 2 nm, using a 1 cm 
path-length. Three repeat scans were made and 
baseline spectra were subtracted from each 
spectra, followed by smoothing using a 5 nm 
window, if required. Data were processed using 
Applied Photophysics Chirascan Viewer, 
Microsoft Excel, and KaleidaGraph 
spreadsheet/graph package. CD ellipticity 
measurements (, millidegrees), were converted to 
 (molar CD, M–1 cm–1) using the relationship  
= /(33000c.l), where c is the molar concentration 
and l is the path length. Note, molar ellipticity 
[degree cm-1 dmol-1)  3300.  
 
Transmission electron microscopy (TEM) —
Aliquots of A samples from the fibre growth 
assays were added to glow-discharged carbon-
coated 300-mesh copper grids (Structure Probe, 
Inc. West Chester, USA.) using the droplet 
method, with water washes before and after 
addition of stain. Phosphotungstic acid (PTA) (2 
% w/v), adjusted to pH 7.4, was used to negatively 
stain the assemblies. PTA was prepared and 
incubated at 37 C̊ for 24-48 hours prior to filtering 
immediately before use. Selected images are 
representative of multiple images that were taken 
over a number of fields and grids. Images were 
recorded using a JEOL JEM-1230 electron 
microscope operated at 80 kV, and the Olympus 
iTEM software package. 
 
Electron Paramagnetic Resonance (EPR) —EPR 
was carried out on a Bruker Elexsys E580 
spectrometer at an X-band (9.38 GHz) microwave 
frequency at 0.5 mW. Single scans were made in 
EPR quartz tubes (outside diameter 4 mm, inside 
diameter 3 mm) with a 2000 G sweep width 
centered at 3000 G and a 10 G modulation 
amplitude. 50 mM of 60% HEPES/40% phosphate 
buffer was used at pH 7.4 for temperature-
independent buffering at 10 K temperatures. 
 
1
H-NMR—1H-NMR spectra were recorded on a 
Bruker AV600 spectrometer Using 500 M of 
EVHHQ peptide in 100% D2O, 30 mM phosphate 
buffer at pH* 7.4.  CuCl2 aliquots were added from 
10 mM. stocks of CuCl2·2H2O in 100% D2O. Data 
was processed and analyzed using TopSpin 2.1 
(Bruker) software. 
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RESULTS 
A(11-40) and A(11-42) rapidly forms amyloid rods—
Although N-terminally truncated A(11-40) and 
A(11-42) constitute 20% of AD plaque load, very 
little is known about their ability to form amyloid 
fibres. We therefore monitored the kinetics of 
A(11-40) and A(11-42) fibre formation using the 
amyloid specific fluorescent dye, thioflavin T 
(ThT). After solubilization at high pH, A(11-40) 
was diluted to 10 M at pH 7.4 and ThT 
fluorescence was monitored over time in a 96-
well-plate reader. The kinetics of A(11-40) fibre 
formation were compared to A(1-40). Like A(1-40) 
a sigmoidal fibre growth curve was consistently 
observed for A(11-40) with a clear nucleation and 
elongation phase, shown in Figure 2a. A(11-40) 
forms fibres significantly faster than A(1-40), with 
an accelerated nucleation and elongation rate. 
Under the same conditions A(11-40) has a 
nucleation time of 27 ± 0.3 hours compared to 65 
± 1 hours for A(1-40). The elongation rates for 
A(11-40) and A(1-40) are 0.44 ± 0.02 hour
-1
 and 0.23 
± 0.04 hour
-1
 respectively. Total maximal ThT 
fluorescence for the two A forms are similar at 
10 M, suggesting both form comparable amounts 
of amyloid, detectable by ThT.  
Next we wanted to investigate the types of A 
assemblies generated. Transmission electron 
microscopy (TEM) of A(11-40), shown in Figure 
2b, consistently revealed stacking of straight, very 
short rod-shaped fibres. Only short, stacked rods 
were observed across multiple peptide batches, 
solubilizations and TEM grids. The rods have a 
similar thickness (ca. 10 nm) to A(1-40) fibres (Fig. 
2c) but are much shorter with the majority being 
under 50 nm in length. These amyloid rods do not 
extend beyond 500 nm, as shown in Figure 2d. 
Furthermore, individual fibre rods tend to self-
associate into clumps much more readily than that 
of the typically long, twisted A(1-40) fibres, shown 
in Figure 2c, formed on the same well-plate under 
the same conditions.  
A(11-42) was also solubilized at high pH with the 
method used for A(11-40). The ThT fluorescence of 
A(11-42) produced a sigmoidal growth curve with a 
nucleation and elongation phase. Under the same 
conditions, both A(11-40) and A(11-42) have quite a 
similar nucleation phase with lag times of 27 ± 0.3 
hours and 25 ± 1 hours respectively, shown in 
Figure 2a. A(11-42) has some fluorescence signal 
directly after solubilization, suggesting some 
amyloid assemblies persist even after 
solubilization.   
TEM images revealed some different 
morphological features for A(11-42) compared with 
A(11-40). A(11-42) contains short stacked rods just 
like A(11-40), figure 2e, but there are also longer 
twisted fibres, figure 2f, often with ragged 
oligomeric assemblies along the length of the 
fibre. Also present are some highly stained 
disordered amorphous aggregates which are in 
greater abundance in A(11-42) than A(11-40) images. 
We were interested in why A(11-40) formed much 
shorter fibre rods. We wondered if A(11-40) rods 
were caused by fibre fragmentation so we 
generated A(11-40) fibres in the absence of the mild 
agitation used in the previous experiment. 
Quiescently generated fibres show a clear change 
in the fibre length of A(11-40).  Although numerous 
short amyloid-rods were present, much longer 
fibres, (which were not observed under mild 
agitation conditions) were also observed, figure 
3a. This suggests that A(11-40) forms exclusively 
short amyloid rods because it readily fragments. 
The differences in quiescently generated A(11-42) 
fibres were less marked but the short rods were 
less abundant with a greater relative abundance of 
longer fibres, figure 3b   
 
Cu
2+
 tetragonal coordination to A(11-40)—There is 
a well-established link between Cu
2+ 
homeostasis 
and AD; we therefore wanted to investigate the 
Cu
2+
 binding properties of A(11-40/42). For this we 
have used visible CD and EPR spectroscopy. 
When bound to proteins and peptides Cu
2+ 
can 
produce very characteristic d-d vis-CD bands 
(54,55). Cu
2+ 
derived vis-CD bands arise from 
amide-main chain coordination being in close 
proximity to the chiral center, fixed in a chelate 
ring (56,57). Figure 4a shows an overlay of the 
vis-CD spectra of the N-terminal residues for 
A(11-40) and a more soluble N-terminal 
pentapeptide A(11-15) (NH2-EVHHQ-Am) with 1:1 
molar equivalents of Cu
2+
. The spectra are almost 
identical, suggesting that only the first few N-
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terminal residues of A(11-40) are involved in 
coordinating Cu
2+ 
ions. 
In light of the possible similarity between Cu
2+
 
binding at the N-terminus of human serum 
albumin (HSA) and A(11-40) (in particular, both 
contain the NH2-XxxXxxHis Cu
2+ 
binding motif) 
we directly compared the vis-CD spectra of Cu
2+
 
loaded A(11-40) with that of HSA and two albumin 
peptide models: NH2-AspAlaHis-Am and NH2-
AlaAlaHis-Am. It is clear from Figure 4b that the 
Vis-CD spectra are very similar.  There are some 
minor differences in the relative intensity of the 
positive and negative CD bands but in comparison 
to the wavelength shifts seen between HSA and its 
N-terminal peptide models, these are not 
significant enough to suggest a different binding 
conformation (58). 
The stoichiometry of the Cu
2+
 A(11-40) interaction 
was investigated though a CuCl2 titration 
monitored by vis-CD with A(11-40) and A(11-15), 
shown in Figure 4c. The CD band intensity 
increases with the addition of Cu
2+
 up to 1 molar 
equivalent, indicating a 1:1 stoichiometry. A 
single set of CD bands are observed throughout 
the titration, suggesting a single complex is 
formed even at low, substoichiometric amounts of 
Cu
2+
. The Cu
2+
 complex is stable over a large 
physiological pH range; with a mid-point for the 
complex of 4.7, at the transition between the CD 
active Cu
2+
 complex and no CD signal. Figure 4d 
shows the pH dependence of the Cu
2+
A(11-15) 
complex. There is no change in the wavelength 
position of the CD bands; indicating that a single 
CD active complex is formed between pH 5.5 and 
10. It is clear the same Cu
2+ 
complex forms over a 
large range of pH values. 
Electron paramagnetic resonance (EPR) was also 
used to study the coordination geometry of the 
Cu
2+
A(11-15) complex. The Cu
2+
 loaded EPR 
spectra exhibited Cu
2+
 type-II spectra typical of a 
square-planar/tetragonal coordination geometry, 
shown in Figure 5a. Furthermore the gII of 2.17 
and hyperfine splitting, AII of 19.3 mK, is most 
indicative of four nitrogen coordinating ligands 
(59). The Cu
2+
A(11-15) EPR spectra bares a close 
resemblance to the EPR spectra of albumin’s N-
terminal Cu
2+ 
binding site, also shown in Figure 
5a. The gII and AII values are very similar, further 
supporting that the Cu
2+
A(11-15) complex has a 
square-planar, four nitrogen coordination similar 
to that found for albumin, with the N-terminal 
amino group, the next two amide main-chain 
nitrogens and the imidazole ring nitrogen 
coordinating, as shown in Figure 5b.  
We were interested in investigating if Cu
2+
 would 
bind to the amyloid fibril rods of A(11-40) in a 
similar manner to the monomer. Using vis-CD we 
show that Cu
2+ 
was able to bind to preformed 
A(11-40) fibre rods. The vis-CD spectra bears a 
close resemblance to the Cu
2+ 
A(11-40) monomer 
complex with comparable wavelengths and 
intensity of vis-CD bands, as shown in Figure 6. 
Fibrillar Cu
2+ 
A(11-40) exhibits 0.7:1 binding 
stoichiometry, close to 1:1. This suggests the Cu
2+ 
binding complex within the first three residues at 
the N-terminus is accommodated within the 
amyloid fibre structure. We note, from this 
binding curve a 0.5:1 stoichiometry, although 
unlikely, cannot be ruled out in fibres.  
 
Femtomolar Cu
2+
 conditional dissociation 
constant for A(11-40)—The affinity of Cu
2+
 binding 
to A(11-40) and its more soluble peptide model 
A(11-15) was determined using a number of 
competitive ligands with known affinities for Cu
2+
. 
The tight affinity of Cu
2+
 for A(11-40) requires a 
highly soluble competitor so glycine and histidine 
were chosen for their relatively high solubility. 
Glycine has a micromolar affinity for Cu
2+ 
and 
forms a bidentate complex via its amino and 
carboxylate groups. While histidine has a 
nanomolar affinity and can coordinate Cu
2+
, 
forming a Cu
2+
(His)2 bidentate complex at 
physiological pH (60). 
The Cu
2+
(Gly)2 complex is CD silent so the vis-CD 
signal for Cu
2+:
A(11-15)
 
can readily be used to 
determine affinity. A very large excess of glycine 
is needed to compete with 100 M of A(11-15) to 
bind Cu
2+
; as much as 3,000 molar equivalents of 
glycine (170 mM) is required to remove half of the 
Cu
2+
 from A(11-15), shown in Figure 7a. Histidine 
has a tighter nanomolar affinity for Cu
2+ 
but it still 
requires 50 molar equivalents (1.4 mM) to remove 
half the Cu
2+ 
ions from A(11-15), Figure 7b. 
Strikingly, it takes more than 100 molar 
equivalents of histidine to compete all of the Cu
2+
 
from A(11-15). At this point the Cu
2+
(His)2 vis-CD 
spectrum becomes apparent with characteristic 
weak positive CD bands at 270 nm and 780 nm. 
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The concentration of competing ligand required to 
remove half of the Cu
2+
 from A(11-15) can be used 
to determine the affinity using equation 1, see 
experimental. The molar ellipticity from the vis-
CD spectra bands at 276 nm, 316 nm, 480 nm and 
558 nm are used to gain an insight into the errors 
in fitting the binding curves. In addition, the 
titrations were repeated for each competitive 
ligand. Table I shows affinities determined with 
histidine and glycine. Using glycine as a 
competitor, a Kd of 2.5 x 10
-14 
M was determined 
at pH 7.4. While for histidine a Kd of 4.2 x 10
-14
 M 
was calculated. An ANOVA shows there is no 
significant difference in the values determined 
using histidine and glycine as competitors with a P 
value of 0.20 across the four titrations. It is clear 
that the conditional dissociation constant at pH 7.4 
of Cu
2+
 for A(11-15) is in the femtomolar range 
with a mean Kd of 34 ± 5 fM determined. The 
agreement in affinity determined using two 
different competing ligands, indicates the 
measurements are not complicated by the 
formation of a ternary complex between Cu
2+
, 
A(11-15) and competitor. 
A similar glycine competition titration of the full-
length monomeric Cu
2+
 A(11-40) complex was 
performed, shown in Figure 7c. A similar Kd of 10 
± 3 fM was measured. This data is less reliable as 
A(11-40) is less soluble and there is some light 
scatter in the data which affects the vis-CD signal, 
however it is clear A(11-40) binds to Cu
2+
 with an 
affinity of 34 fM or tighter. 
 
Evidence for square-pyramidal His14 coordination 
of Cu
2+
 —The affinities determined for A(11-40), 
in Table I, are tighter than those reported for 
human serum albumin and we considered the 
possibility that the higher affinity might be due to 
the presence of a second histidine residue, His14, 
four residues from the N-terminus. To investigate 
this we generated a peptide analogue with an 
alanine substitution at the His14 site. Using 
competing ligands we determined the affinity of 
Cu
2+
 for A(11-15) His14Ala.  In this way we have 
determined if His14 has an influence on the Cu
2+ 
affinity. The dissociation constant at pH 7.4, 
determined using glycine or histidine as competing 
ligands, was 136 ± 23 fM. This value is slightly 
weaker than the complex with His14 present, with a 
P value of < 0.05 showing a significant difference 
between His14 and alanine substituted A(11-15) 
affinities. Based on the Kd data it does appear 
His14 has an influence on the affinity of Cu
2+ 
for 
A(11-40).    
The Cu
2+ 
vis-CD and UV-vis absorption spectra of 
A(11-15) are very similar compared to the His14Ala 
analogue, with a high degree of similarity between 
the vis-CD band wavelengths and intensities. In 
addition, the visible absorption spectra for Cu
2+
 
A(11-15) and A(11-15) His14Ala, are very similar. A 
max at 525 nm and a molar extinction coefficient 
525 of 110 M
-1
cm
-1  
for both peptides are indicative 
of other NH2-XxxXxxHis Cu
2+ 
complexes (45). 
This further supports the formation of a 
characteristic NH2-XxxXxxHis Cu
2+ 
complex 
similar to that of the N-terminal Cu
2+ 
binding site 
of albumin. 
We wanted to use 
1
H-NMR to help further resolve 
this question. Addition of paramagnetic Cu
2+
 
causes a loss of A(11-15) 
1
H NMR signal intensity 
with increasing additions of Cu
2+
.  Cu
2+
 bound 
1
H 
NMR signals are not observed due to the 
paramagnetic properties of Cu
2+
, which cause 
significant line-broadening of 
1
H-NMR signals.  
There is no difference in the extent to which signal 
is lost between His13 and His14 resonances as Cu
2+ 
is added, which is consistent with a role for His14 
in axial coordination. However this could be due 
to the proximity of His14 ring protons to Cu
2+ 
rather than direct coordination, as all the side-
chain resonances are extensively broadened. 
 
Cu
2+
 and A(11-40) fibre formation—We have 
shown A(11-40) has an appreciable femtomolar 
affinity for Cu
2+
, we therefore wanted to 
investigate how the presence of Cu
2+ 
ions might 
affect the kinetics and morphology of A(11-40) 
fibre formation. ThT fluorescence indicates that 
the presence of 0.1 molar equivalents of Cu
2+ 
has 
little effects on fibre kinetics, while 0.2 molar 
equivalents causes a reduction in the total ThT 
signal by approximately 40%, see figure 8a. A 
similar ThT signal reduction is observed with 0.4 
molar equivalents of Cu
2+
 but there is a prominent 
reduction in elongation rate, with kapp slowing 
from 0.54 ± 0.02 hours-1 for apo to 0.21 ± 0.04 
hours
-1
. For 1 and 10 molar equivalents of Cu
2+
,
 
no 
ThT signal is observed over more than 100 hrs. 
Interestingly, not only do small substoichiometric 
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amounts of Cu
2+
 perturb the kinetics of A(11-40) 
fibre formation, and the total amount of ThT 
bound to amyloid, but Cu
2+
 also affects the 
morphology of the fibres generated. In the absence 
of Cu
2+
,
 
A(11-40) exclusively generates short 
amyloid rods (mostly 50 - 200 nm in length) under 
mildly agitating conditions, as shown in Figure 2. 
However, with fibres generated under the same 
mild agitation, the TEM images show that short 
rods only partially remain; even in the presence of 
small substoichiometric concentrations of 0.2 
equivalents of Cu
2+
. However, there are also 
similar amounts of much longer, twisted fibres 
with a morphology more reminiscent of A(1-40), 
shown in Figure 8b. At just 0.4 equivalents Cu
2+
, 
EM grids contain almost exclusively long fibrillar 
assemblies. Counter intuitively, although at 0.4 
molar equivalents of Cu
2+ 
the ThT signal is 
attenuated, the EM images show numerous and 
wide-spread long amyloid fibres, Figure 8c, but 
there is an increased amount of amorphous 
aggregates compared to lower Cu
2+ 
equivalents. 
Beyond 1 molar equivalent of Cu
2+
 the TEM 
images are dominated by amorphous aggregates 
with dense irregular staining of the aggregates, not 
shown, which do not cause ThT fluorescence. 
We were also interested in discovering if the long 
fibres generated in the presence of Cu
2+ 
revert to 
short rods in the presence of a strong Cu
2+
 
chelator, for this experiment we added 
Ethylenediaminetetraacetic acid (EDTA) which 
has a Ka of 10
18
 for Cu
2+
. The addition of EDTA to 
A(11-40) fibres, generated in the presence of 0.4 
molar equivalents Cu
2+
, caused the ThT 
fluorescence signal to increase to a similar 
intensity to that observed for apo A(11-40), as 
shown in Figure 9a, thus any reduction in ThT 
bound fibres is rapidly reversible. Interestingly 
TEM images of these A(11-40) fibres grown with 
Cu
2+ 
revert to very short stacks of amyloid rods, 
like those seen for fibres of A(11-40) only.  This 
observation suggests that Cu
2+
 has a stabilizing 
effect on A(11-40) fibres, preventing fragmentation, 
but once Cu
2+
 is removed, all the fibres rapidly 
fragment into amyloid rods, as shown in Figure 
9b. 
Next we wanted to see if Cu
2+
 addition affects the 
morphology of preformed A(11-40) amyloid rods as 
well. We know from Figure 6 that Cu
2+ 
can bind to 
preformed amyloid fibres. Addition of Cu
2+
 to 
preformed amyloid rods of A(11-40) caused a 32% 
reduction in ThT fluorescence. This reduced the 
intensity of fluorescence to a similar level to the 
maximum fluorescence observed for A(11-40) 
fibres grown in the presence of 0.4 molar 
equivalents of Cu
2+
. TEM images, shown in Figure 
9c, demonstrate that addition of Cu
2+
 to the 
preformed, fragmented amyloid rods had no 
discernible effect over a 70 hour period. 
 
Cu
2+
 and A(11-42) fibre formation—We have 
recently shown, the effect of Cu
2+ 
on fibre growth 
can markedly vary depending on the isotype of A 
present (24). In particular, substoichiometric Cu
2+ 
causes A(1-40) to form fibres but with A(1-42) only 
protofibrils and oligomers are observed. We 
therefore wanted to investigate the effect of Cu
2+ 
on A(11-42) fibre growth to assess how the two C-
terminal amino acids influence Cu
2+ 
dependent 
kinetics. As with A(11-40), increasing the molar 
equivalents of Cu
2+ 
causes the maximum ThT 
signal of each A(11-42) fibre growth curve to 
decrease. The ThT signal reduction caused by 0.4 
molar equivalents of Cu
2+
 is similar to A(11-40), 
with a reduction for A(11-42) of ca. 50%. The effect 
of Cu
2+
 on A(11-42) elongation rate was similar to 
A(11-40) with a slower rate with increasing Cu
2+ 
levels.  
The representative TEM images of A(11-42) 
nucleated with Cu
2+
, shown in Figure 8e and 8f, 
complimented the decrease in ThT fluorescence 
observed as A(11-42) was grown with higher 
equivalencies of Cu
2+
. There was a general 
decrease in short amyloid rod stacks while longer 
fibres were more abundant as more Cu
2+
 was 
added. There were also shorter, “curvy” 
assemblies with a morphology often observed for 
protofibrillar assemblies at 0.4 molar equivalents 
Cu
2+
. The promotion of A(11-42) protofibril 
generation by Cu
2+ 
is similar to the effect observed 
for Cu
2+ 
with A(1-42) but the effect was by no 
means as universal as it is for A(1-42) (24). 
 
DISCUSSION 
A(11-40/42) rapidly forms amyloid rods—
Appreciable levels of A(11-40/42) are present in the 
CSF, produced by the action of BACE at the ʹ 
cleavage site of APP (10,11). Furthermore mean 
levels of A within plaques from sporadic AD 
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patients have been shown to contain 19% A(11-42), 
comparable to A(1-42) levels (12,13). Despite this, 
perhaps because of its poor solubility (18), very 
few in vitro studies of A(11-40/42) have been 
reported, with studies focusing almost exclusively 
on A(1-40/42). This is the first study describing the 
kinetics of A(11-40/42) fibre formation and its 
interaction with Cu
2+ 
ions. 
Under the same conditions (10 M A, pH 7.4, 
mild agitation) both A(11-40) and A(11-42) form ThT 
binding amyloid assemblies more than twice as 
fast as A(1-40). Thus the rapid formation of 
amyloid rods of A(11-40/42), that we observe, may 
be important in plaque deposition. The 
amyloidogenicity of A sequences are often 
thought to correlate with disease progression. A(1-
42) forms fibres much faster than A(1-40) and is also 
more toxic in vivo (61-64). The heightened rate of 
fibre nucleation and elongation observed for A(11-
40/42) may be caused by the loss of negatively 
charged side-chains as it is known that the pI and 
charge of A have a profound influence on its rate 
of fibre formation (22,65). The absence of a 
number of charged residues at the N-terminus 
increases the theoretical pI from 5.1 for A(1-40/42) 
to 6.0 for A(11-40/42). Consequently, at 
physiological pH 7.4, A(11-40) is more neutrally 
charged and will much more readily self-associate 
into nucleating oligomers and elongate more 
rapidly into fibres. A(11-40) fibres generated 
quiescently form much longer fibres indicating 
A(11-40) fibres fragment more easily than A(1-40). 
It is known that secondary nucleation events can 
dominate the kinetics of fibre formation and 
influence cytotoxicity (66,67). The rapid fibre 
formation for A(11-40) might be due, impart to its 
propensity to fragment and cause secondary 
nucleation. 
We were interested by the markedly shorter rod-
like fibres observed for apo A(11-40) and A(11-42) 
compared to A(1-40). With the exception of the A 
Osaka mutant (A22) (68), the first ten residues 
of A(1-40/42) have been shown not to typically be 
directly involved in the core structure of most 
amyloid fibres generated in vitro, and are not 
thought to form any stable hydrogen bonded 
structure (69-71), despite this our data shows these 
residues have a profound influence on the 
appearance (length) of the fibres. It is possible that 
the N-terminal residues (1-10) have a stabilizing 
influence on the amyloid fibres as they form. 
A(11-42) also forms largely short amyloid rods 
under mildly agitating conditions, although longer 
fibres are present, the two additional C-terminal 
residues could possibly stabilize the 
intermolecular forces along the fibre. 
 
Cu
2+
 and A(11-40/42)—The presence of the histidine 
three residues from the N-terminus facilitates the 
formation of a high affinity Cu
2+
 complex. A(11-40) 
and the model peptide A(11-15) have a 34 ± 5 fM 
conditional dissociation constant for Cu
2+
 at pH 
7.4. This indicates A(11-40/42) binds to Cu
2+ 
with a 
thousand times tighter affinity compared to A(1-
40/42) (35). It is clear that A(11-40/42) will 
preferentially bind any available extracellular Cu
2+ 
ions. Indeed A(11-40) has an affinity more than an 
order of magnitude tighter than the extracellular 
Cu
2+ 
transport protein human serum albumin 
(HSA). This has ramifications for the ability of 
A(11-40/42) to compete for Cu
2+
 ions at the synapse. 
Cu
2+ 
is released at the synapse during neuronal 
depolarization and is thought to reach levels 
between 15 and 200 M (38). CSF levels of Cu2+ 
are lower, at 500 nM, (72) but the femtomolar 
affinity of A(11-40/42) will readily bind Cu
2+ 
even at 
these lower concentrations. The total soluble A 
concentration in the CSF is 0.1 – 0.5 nM (11), so 
with such a high affinity for Cu
2+ 
much of the 
A(11-40/42) is likely to be coordinating Cu
2+ 
ions. It 
is notable that the most abundant protein in the 
CSF, the Cu
2+
 transport protein serum albumin, 
reaches levels of 3 M but has an affinity for Cu2+ 
more than
 
an order of magnitude weaker than 
A(11-40/42) and will therefore only partially 
compete for Cu
2+ 
ions bound to A(11-40/42). A(11-
40/42) can constitute up to 19% of the plaque load 
(12), and its presence can explain the very high 
levels of Cu
2+ 
found in the plaques of AD patients 
(25-28). 
The visible absorbance, vis-CD, EPR spectra, pH 
dependence, stoichiometry and NMR data are all 
initially consistent with the formation of a 4N, N-
terminal complex shown in Figure 5b. We 
considered the possibility of the involvement of 
the imidazole nitrogen of His14 coordinating 
axially, perpendicular to the 4N plane. There is 
little difference in the absorbance spectra or 
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visible CD between the A(11-15) model peptide and 
A(11-15) H14A, which might suggest His14 is not 
involved in coordination, however axial 
coordination can have minimal influence on 
absorbance spectra for Cu
2+
 square-pyramidal 
complexes. There is a significant loss of affinity 
with the removal of the second histidine which 
suggests that His14 has an influence on 
coordination, forming a square pyramidal complex 
with axial coordination from the imidazole of 
His14, making the affinity of A(11-40/42) 
considerably tighter than that observed for serum 
albumin (HSA) at 1.0 pM (46). 
The vis-CD spectra generated for Cu
2+ 
A(11-40) 
monomers and fibres are almost identical, 
indicating that Cu
2+ 
binds to fibres with a similar 
coordination to that of the monomer. Vis-CD 
spectra are extremely sensitive to coordination; the 
intensity and even sign of the CD bands will be 
greatly influenced by even small changes in 
geometry (57,58). Cu
2+
 cross-linking between two 
adjacent A molecules is not supported by the 
data. In particular, the loss of main-chain amide 
coordination to be replaced by side-chain 
coordination from a histidine imidazole of a 
second A molecule is likely to cause a profound 
change in the appearance of the CD bands, which 
is not observed. The ability of amyloid fibres to 
accommodate Cu
2+
 binding has also been observed 
for A(1-40) and A(1-42) (35,73-76). Interestingly, 
Cu
2+
 can diffuse into and load on to all A 
molecules within the fibres and facilitate the Cu
2+
 
coordination with close to 1:1 stoichiometry. 
It is not clear why the presence of Cu
2+ 
would 
promote markedly longer fibres compared to the 
much shorter, rod-like fibres observed for apo 
A(11-40), generated under the same conditions of 
mild agitation. The binding of Cu
2+
 ions appears to 
stabilize longer fibres that would otherwise 
fragment into shorter rods. This is supported by 
the effect of EDTA addition to Cu
2+ 
A(11-40) fibres 
which results in rapid fragmentation of A(11-40) 
into shorter amyloid rods. The molecular packing 
of A(11-40) fibres in the presence of Cu
2+
 seems to 
produce a greater fibre stability against shearing 
forces that cause fragmentation (66). We suggest 
that at pH 7.4, the addition of Cu
2+ 
will add 
positive charge to A(11-40), and with a pI of 6.0 
A(11-40) may be closer to charge neutrality which 
might stabilize fibres. Potentially the Cu
2+ 
complex 
could cross-link between the His13 and His14 
residues of two adjacent A molecules within a 
fibre, stabilizing the extension of the fibre 
resulting in longer structures, however there is no 
evidence for a change in coordination geometry 
for A(11-40) monomer or fibres, so this seems 
unlikely. 
The marked influence of the two C-terminal 
residues (Ala41Val42) on A assembly and 
morphology in the presence of Cu
2+ 
has 
implications for cytotoxicity and membrane 
disruption. Cu
2+ 
loaded A(11-42) generates some 
“curvy”, short assemblies reminiscent of the 
protofibril and oligomer structures observed 
exclusively when substoichiometric Cu
2+
 is added 
to A(1-42) fibres (24). 
 
In conclusion, the N-terminally truncated form of 
A constitutes relatively high levels in the CSF 
and plaques of Alzheimer’s patients (11-13). Here 
we show A(11-40/42) has marked amyloidogenicity 
and a femtomolar affinity for Cu
2+
. The affinity of 
Cu
2+ 
for A has been a source of much attention, 
with much debate surrounding the ability of A(1-
40/42) to retain Cu
2+ 
in vivo with a 50 pM affinity 
(35). The 34 femtomolar conditional affinity of 
A(11-40/42) for Cu
2+ 
is considerably tighter than 
extracellular competitors, such as serum albumin. 
We suggest the high abundance (19%) of A(11-
40/42) in plaques (12,13) must contribute to the high 
levels of Cu
2+
 reported in plaques (25,27,28). 
Furthermore a second N-terminally truncated form 
of A, residues 4-40/42, is also found in plaques 
and typically makes up 6% of plaque load 
(12). This peptide also contains a histidine at the 
third position from the N-terminus and has 
recently been shown to bind Cu
2+
 with a sub-
picomolar affinity (77). A further N-terminally 
truncated form, A(3-40/42) is also found within 
plaques and is thought to constitute 2% of plaque 
load  (12).  Its Cu
2+
 binding properties have been 
carefully described (78). This complex does not 
have a histidine at the third position and forms a 
Cu
2+
 complex more similar to A(1-40/42).  Cu2+ 
within the plaques can convert A(1-42) fibres into 
protofibrils/oligomers which suggests a 
mechanism to generate more toxic A species 
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(24). Furthermore, the concentration of redox 
active Cu
2+
 within plaques can explain the high 
levels of methionine sulfoxide as well as di-
tyrosine formation observed in A plaques 
(27,79). The femtomolar affinity of A(11-40/42) for 
Cu
2+
 has implications for chelation therapies 
targeting extracellular Cu
2+
, and the mode of 
action of Clioquinol and its derivatives (32,34).  
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FIGURE LEGENDS 
 
FIGURE 1. - and ʹ- secretase processing of amyloid precursor protein (APP). The ʹ activity of the 
beta-site amyloid precursor protein cleaving enzyme 1 (BACE-1) N-terminally truncates A before Glu11. 
-secretase cleaves the C-terminus most commonly at position 40 or 42, within the lipid bilayer. The -
secretase produces P3 which starts at Lys17. The percentages of typical A plaque load are also 
indicated; 19% for A(11-40/42). 
 
FIGURE 2. A(11-40) and A(11-42) form amyloid rods. ThT Fluorescence follows the fibre growth of A(11-
40) (blue), A(11-42) (green) and A(1-40) (red) (a). Representative TEM images of A(11-40) (b), A(1-40) (c) and 
A(11-42) (e,f) negatively stained with phosphotungstenic acid, the scale bar is 200 nm. Fibre lengths were 
measured for A(11-40) (blue) and A(1-40) (red) and their percentage frequency is shown in (d). N-terminally 
truncated Aforms fibres more rapidly than full length A and produces short stacked amyloid rods, mild 
intermittent agitation for all conditions, 10 M peptide, 10 M ThT, 30 mM HEPES, 160 mM NaCl at pH 
7.4. 
 
FIGURE 3. Quiescently grown fibres of A(11-40) (a) and Aβ(11-42) (b). Representative TEM images after 
20 days incubation at room temperature with no agitation, 10 M peptide, pH 7.4, 160 mM NaCl, 30 mM 
HEPES. Under quiescent growth conditions much longer fibres are observed. Scale bars are 200 nm. 
 
FIGURE 4. Cu
2+
 visible CD of A(11-40) and A(11-15). Overlaid spectra of A(11-40) (red), A(11-15) (green) 
(a). Comparison of N-terminally truncated A(11-40) (red) and A(11-15) (green) with albumin (orange) and 
its peptide mimics AAH (blue) and DAH (purple) (b). Cu
2+
 titration with A(11-15) shows signal saturation 
at 1:1 stoichiometry (spectra as inset) The dotted lines are straight line fits to the initial data points 
and the points in which saturation is apparent.  (c). pH dependence of the EVHHQ Cu2+ complex, 
pKa = 4.7 (spectra are shown as inset) (d). 100 M Peptides, pH 7.4. 
 
FIGURE 5. Comparison of Cu
2+
-EPR spectra of Cu
2+
 A(11-15) with Cu
2+
 DAH (The N-terminal residues 
of albumin AspAlaHis). EPR shows highly similar spectra, indicating the same 4N square-planar 
coordination geometry (a). 100 M Peptides, 90 M CuCl2 at pH 7.4 in 50 mM 60% HEPES/40% 
phosphate buffer. Proposed 4N square planar coordination geometry of Cu
2+
 A(11-40). Axial coordination 
from the imidazole nitrogen of His14 is also probable (b). 
 
FIGURE 6. Cu
2+
 binds to A(11-40) fibres. A comparison of vis-CD spectra of Cu
2+ 
loaded monomer (red) 
and fibres (blue) of A(11-40). The inset shows A(11-40) fibres loading Cu
2+
 with approximate 1:1 
stoichiometry (0.7 : 1). Preformed A(11-40) fibres (70 M) were generated prior to Cu
2+
 titration, pH 7.4. 
A(11-40) fibres can accommodate Cu
2+
 binding in the same manner as the monomeric form, with similar 
CD bands and intensities. 
 
FIGURE 7. Cu
2+
 affinity for A(11-40) competitive titrations. Visible CD of A(11-15) using L-histidine (a) 
and glycine competitors (b). Cu
2+
 A(11-40) complex titrated with glycine (c). The dotted line shows the 
concentration of competitor needed to remove half the Cu
2+
 from the A peptides. Inserts show vis-CD 
spectra with increasing concentrations of competitor. All experiments were carried out at pH 7.4 with 
A(11-15) at 100 M. A(11-40) is at 72 M. 
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FIGURE 8. Influence of Cu
2+
 on A(11-40) and A(11-42) fibre growth. ThT Fluorescence of A(11-40) and 
A(11-42) fibre growth with different molar equivalencies of Cu
2+,
 (a) and (d) respectively. TEM images of 
fibres produced with the following Cu
2+
 equivalencies: A(11-40) 0.1 (b) 0.4 (c). A(11-42) 0.1 (e) 0.4 (f). All 
scale bars are 50 nm. 
 
FIGURE 9. Reversibility of Cu
2+
 influence on A(11-40) fibres. The effect of 0.4 molar equivalents Cu
2+ 
on 
pre-formed A(11-40) fibres and removal of Cu
2+ 
from Cu
2+ 
A(11-40) fibres. ThT Fluorescence of A(11-40) 
fibre growth with subsequent addition of 0.4 molar equivalents Cu
2+
 at 235 hrs. Also showing fibre 
growth of A(11-40) in the presence of Cu
2+ 
with later addition of 0.4 molar equivalents of EDTA
 
(a). ThT 
fluorescence kinetics traces are an average from n = 6, error bars are SEM. TEM images of the fibres 
produced with Cu
2+ 
added to preformed fibres
 
(b) 
 
and Cu
2+
 A(11-40) fibres with subsequent EDTA 
addition (c).
 
Scale bars are 200 nm. 
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TABLES 
 
TABLE 1. Femtomolar conditional dissociation constants (Kd) at pH 7.4 shown for A(11-40) and its 
peptide models A(11-15) and A(11-15) His14Ala. 
 
Peptide Glycine Histidine Mean 
A(11-15) 
27 ± 3 
and 
24 ± 3 
50 ± 16 
and 
34 ± 2 
34 ± 5 fM 
A(11-40) 10 ± 3 ̶ 10 ± 3 fM 
A(11-15) 
H14A 
186 ± 27 87 ± 9 136 ± 23 fM 
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FIGURE 3 
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FIGURE 4 
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FIGURE 5 
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FIGURE 6 
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FIGURE 7 
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FIGURE 8 
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FIGURE 9 
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